UK Biotechs Present Novel Technologies at BioTrinity 2017
Biotechnology Rolls on Despite Brexit Uncertainty
Avoiding Costly Errors in Bioassay Development
Developers Have a Range of Options When Optimizing Bioassays for Biologics
Screening Innovations and 3D Cell Culture Assay Developments
Showcased at ELRIG
New Tech Aids Drug Discovery
In Scientific Publishing, Sharing Is Caring
The Saga for Open-Access Research Continues
Sagar Anisingaraju is the Chief Strategy Officer of Saama Technologies. He is passionate in helping customers derive business outcomes and a differentiating analytics advantage with their data assets. He was the winner of the ‘Chief Strategy Officer of the Year’ award from Innovation Enterprise in 2013. His recent contributions include architecting advanced analytics engine and solutions for a variety of industries. This analytics engine is used by Life Sciences companies to capture and manage data at all stages of the value chain: from Bench to Bedside to derive insights and implement proactive programs. He is a contributor to publications on use of Big Data by pharma companies and providers.
Prior to joining Saama, Sagar founded and ran InfoSTEP Inc. for 11 years as CEO till its acquisition by Saama.
More GEN Content From This Contributor
- GEN Exclusives: Optimizing Clinical Trials